Search - tctmd.com

Displaying 161 - 180 of 227

Sort: Relevancy | Date

Presentation TVT 2021

Impact of MAC on Patient Selection, Procedural Success and 1-Year Outcomes in a Real-World Patient Population Evaluated for TMVI: Results From the CHOICE-MI MAC Study

Presenter: Walid Ben Ali

July 21, 2021

Presentation TVT 2021

Transapical Mitral Valve Implantation for Treatment of Symptomatic Mitral Valve Disease: A Real-world Multicenter Experience

Presenter: Jörg Hausleiter

July 21, 2021

Presentation TVT 2021

Case Resolution: LVOT Obstruction After Mitral ViMAC

Presenter: Mayra Guerrero

July 20, 2021

Presentation TVT 2021

Case Introduction: LVOT Obstruction After Mitral ViMAC

Presenter: Mayra Guerrero

July 20, 2021

Presentation TVT 2021

Case Resolution: Late Symptomatic Mitral Stenosis After TEER

Presenter: Adam Greenbaum

July 20, 2021

Presentation TVT 2021

Case Introduction: Late Symptomatic Mitral Stenosis After TEER

Presenter: Adam Greenbaum

July 20, 2021

Presentation TVT 2021

Case Resolution: Residual ASD After TEER

Presenter: Howard Herrmann

July 20, 2021

Presentation TVT 2021

Case Introduction: Residual ASD After TEER

Presenter: Howard Herrmann

July 20, 2021

Presentation TVT 2021

Randomized Trials Are Nice to Have but Not Always Practical!

Presenter: Martin B. Leon

July 20, 2021

Presentation TVT 2021

Randomized Trials Are a Must!

Presenter: Jason H. Rogers

July 20, 2021

Presentation TVT 2021

Not Today, and Probably Not Tomorrow!

Presenter: David H. Adams

July 20, 2021

Presentation TVT 2021

Ready for Prime Time Today!

Presenter: Saibal Kar

July 20, 2021

Presentation TVT 2021

There Is No Such Thing as Maximally-Tolerated GDMT: Use a Real-world Approach!

Presenter: Milton Packer

July 20, 2021

Presentation TVT 2021

Try Maximally-Tolerated GDMT First!

Presenter: JoAnn Lindenfeld

July 20, 2021

Presentation TVT 2021

MitraClip and Pascal in FMR: Technical Approaches and Considerations

Presenter: Neil Fam

July 20, 2021

Presentation TVT 2021

Should Patient Selection for TEER in FMR Be Limited to the COAPT Criteria?

Presenter: Sean Pinney

July 20, 2021

Presentation TVT 2021

Optimal Medical Therapy and Timing of TEER

Presenter: JoAnn Lindenfeld

July 20, 2021

Presentation TVT 2021

Mitral Valve

Presenter: Gagan Singh

July 20, 2021

Presentation TVT 2021

MASTER CLASS #4: Hemodynamics of Mitral Regurgitation

Presenter: Daniel Burkhoff

July 20, 2021

Presentation TVT 2021

MASTER CLASS #3: Echo Imaging in TEER

Presenter: G. Burkhard Mackensen

July 20, 2021

Advertisement

Impact of MAC on Patient Selection, Procedural Success and 1-Year Outcomes in a Real-World Patient Population Evaluated for TMVI: Results From the CHOICE-MI MAC Study

Transapical Mitral Valve Implantation for Treatment of Symptomatic Mitral Valve Disease: A Real-world Multicenter Experience

Case Resolution: LVOT Obstruction After Mitral ViMAC

Case Introduction: LVOT Obstruction After Mitral ViMAC

Case Resolution: Late Symptomatic Mitral Stenosis After TEER

Case Introduction: Late Symptomatic Mitral Stenosis After TEER

Case Resolution: Residual ASD After TEER

Case Introduction: Residual ASD After TEER

Randomized Trials Are Nice to Have but Not Always Practical!

Randomized Trials Are a Must!

Not Today, and Probably Not Tomorrow!

Ready for Prime Time Today!

There Is No Such Thing as Maximally-Tolerated GDMT: Use a Real-world Approach!

Try Maximally-Tolerated GDMT First!

MitraClip and Pascal in FMR: Technical Approaches and Considerations

Should Patient Selection for TEER in FMR Be Limited to the COAPT Criteria?

Optimal Medical Therapy and Timing of TEER

Mitral Valve

MASTER CLASS #4: Hemodynamics of Mitral Regurgitation

MASTER CLASS #3: Echo Imaging in TEER

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content